X

Vous n'êtes pas connecté

Maroc Maroc - ZACKS.COM - All Stories - 10/Jul 13:30

Is GSK an Attractive Drug Stock to Add to Your Portfolio Now?

Strong sales growth of GSK's specialty drugs and vaccines, the contribution from new products and positive pipeline updates make the stock attractive

Articles similaires

Sorry! Image not available at this time

Reasons to Add New Jersey Resources Stock to Your Portfolio Now

zacks.com - 02/Sep 11:57

NJR makes a strong case for investment, given its growth prospects, strong ROE and capability to increase shareholders' value.

Sorry! Image not available at this time

Reasons to Add Teledyne Technologies Stock to Your Portfolio Now

zacks.com - 03/Sep 12:57

TDY makes a strong case for investment in the aerospace sector, given its long-run growth prospects, low debt and strategic acquisitions.

Sorry! Image not available at this time

Reasons to Add Northwest Natural Stock to Your Portfolio Now

zacks.com - 10/Sep 13:03

NWN makes a strong case for investment, given its growth prospects, better debt management and capability to increase shareholders' value.

Sorry! Image not available at this time

Reasons to Add Northwest Natural Stock to Your Portfolio Now

zacks.com - 10/Sep 13:03

NWN makes a strong case for investment, given its growth prospects, better debt management and capability to increase shareholders' value.

Sorry! Image not available at this time

Here's Why You Should Add SJW Group Stock to Your Portfolio Now

zacks.com - 04/Sep 13:06

SJW makes a strong case for investment, given its growth prospects, prudent debt management and capability to increase shareholder value.

Sorry! Image not available at this time

Here's Why You Should Add SJW Group Stock to Your Portfolio Now

zacks.com - 04/Sep 13:06

SJW makes a strong case for investment, given its growth prospects, prudent debt management and capability to increase shareholder value.

Sorry! Image not available at this time

Here's Why You Should Retain Glaukos Stock in Your Portfolio Now

zacks.com - 09/Sep 17:36

GKOS continues to benefit from a robust demand for its products as well as expansion in new markets. A strong development pipeline raises optimism.

Sorry! Image not available at this time

Here's Why You Should Retain Glaukos Stock in Your Portfolio Now

zacks.com - 09/Sep 17:36

GKOS continues to benefit from a robust demand for its products as well as expansion in new markets. A strong development pipeline raises optimism.

Sorry! Image not available at this time

Reasons to Add Xcel Energy Stock to Your Portfolio Right Now

zacks.com - 28/Aug 13:12

XEL makes a strong case for investment given its growth prospects, strong ROE, highly efficient operations and capability to increase shareholders'...

Sorry! Image not available at this time

Biogen Stock Declines 20.9% Year to Date: Time to Sell?

zacks.com - 03/Sep 14:06

BIIB's reasonable valuation, an improving pipeline and better sales prospects of new drugs are good enough reasons to stay invested for now.